ArticleOncotarget2022

Kinase activity profiling in renal cell carcinoma, benign renal tissue and in response to four different tyrosine kinase inhibitors.

Andliena Tahiri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.